Mechanism of action
Para-aminosalicylic acid (PAS) is a second-line anti-TB drug (SLD) that was found to be effective for treatment of TB in the 1940s. As a structural analog of p-aminobenzoic acid, it disrupts folate metabolism through competitive binding with dihydrofolate reductase, thereby inhibiting the growth of tubercle bacilli.